Company intelligence / Profile preview

EUDA Health

Singapore, Singaporeeuda.com ↗

Ownership: Public · EUDA
Development stage: Commercial

Overview

EUDA operates a digital healthcare platform in Southeast Asia that integrates telemedicine with AI-powered analytics for personalized care. The company has expanded its offerings to include non-invasive wellness products and recently began offering stem cell therapies through partnerships. Clinical results are not detailed as the focus is on service delivery rather than drug development trials.

Therapeutic areas: Other
Modalities: Non-invasive wellness productsStem cell therapy
Industry: Non-Academic Healthcare

Partnerships

Guangdong Cell Biotech (strategic partnership/joint venture discussions for stem cell therapies)Authorized distributor of Guangdong Cell Biotech in Singapore/Malaysia for stem cell product distribution

Financials

Market cap: $44.4M
Total revenue: $6.8M
Enterprise value: $44.3M

Beyond the preview

Go deeper on EUDA Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EUDA Health.